Revenue
2016
2017
2018
2019
2020
2021
2022
2023
PALVELLA THERAPEUTICS, INC. (PVLA)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2016
2017
2018
2019
2020
2021
2022
2023
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 · Dec 31 | 2014 · Jun 30 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $38.7M | $25.5M | $27.9M | $23.9M | $43.6M | $27.2M | $25.3M | $5.8M | $2.9M | $5.4M | $0 | $12.4M |
| Research & development | $22.8M | $8.2M | $8.8M | $53.0M | $66.7M | $46.5M | $55.0M | $41.5M | $22.3M | $19.7M | $8.2M | $5.6M | — | $9.4M |
| Operating expenses | $38.6M | $14.1M | $11.9M | $69.4M | $83.2M | $63.2M | $73.4M | $59.9M | $39.9M | $28.6M | $16.6M | $12.6M | $15,712 | — |
| Operating income | −$38.6M | −$14.1M | −$11.9M | −$43.5M | −$51.8M | −$33.9M | −$27.2M | −$30.8M | −$14.6M | −$22.8M | −$13.7M | −$7.2M | −$15,712 | $553,826 |
| EBITDAderived | — | — | −$10.0M | −$40.7M | −$49.4M | — | — | — | — | — | — | — | — | — |
| Net income | −$41.7M | −$17.4M | $18.7M | −$33.3M | −$45.7M | −$37.2M | −$25.5M | −$26.8M | −$17.6M | −$22.8M | −$14.1M | −$9.8M | −$15,712 | $66,196 |
| Basic EPSper diluted share | -$3.71 | -$7.83 | $2.19 | -$0.45 | -$0.71 | -$0.68 | -$0.56 | -$0.50 | -$0.40 | -$0.55 | -$0.41 | -$0.71 | $0.00 | $0.01 |
| Diluted EPSper diluted share | -$3.71 | -$7.83 | $2.17 | — | -$0.71 | -$0.68 | -$0.56 | -$0.50 | -$0.40 | -$0.55 | -$0.41 | -$0.71 | $0.00 | $0.01 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 17, 2026Form 4 · 10b5-1 | Goin KathleenChief Operating Officer | SellCommon Stock | 25 | $112.23 | $2.8K | 0 |
| Jun 17, 2026Form 4 · 10b5-1 | Goin KathleenChief Operating Officer | SellCommon Stock | 1.9K | $111.31 | $210.0K | 25 |
| Jun 17, 2026Form 4 · 10b5-1 | Goin KathleenChief Operating Officer | SellCommon Stock | 2.4K | $110.26 | $263.5K | 1.9K |
| May 20, 2026Form 4 · 10b5-1 | Goin KathleenChief Operating Officer | SellCommon Stock | 48 | $111.90 | $5.4K | 0 |
| May 20, 2026Form 4 · 10b5-1 | Goin KathleenChief Operating Officer | SellCommon Stock | 891 | $111.30 | $99.2K | 48 |